Antiretroviral News and Research

RSS

Unlocking the anti-inflammatory secrets of bergamot byproducts

The positive effect of bergamot derivatives.

17 Jan 2024

Study finds that HIV populations in people with higher viral loads also have higher rates of viral recombination

Researchers investigated whether denser intrahost HIV populations had a higher incidence of coinfection and recombination.

15 Jan 2024

Paxlovid treatment in 20% of COVID-19 patients could avert 850,000 hospitalizations, save up to $170 billion

A study in the Emerging Infectious Diseases journal shows treating 20% of COVID-19 patients with Paxlovid could save up to 0.85 million lives and reduce the economic burden by US $170.17 billion in the US.

14 Jan 2024

New study offers hope for reducing malaria in pregnant women living with HIV

In women living with HIV, preventive treatment with DHA-PPQ is a safe and effective strategy to prevent malaria during pregnancy, according to the final results of MAMAH, a clinical trial funded by the European & Developing Countries Clinical Trials Partnership (EDCTP) and coordinated by the Barcelona Institute for Global Health (ISGlobal), an institution supported by "la Caixa" Foundation.

12 Jan 2024

Rising out-of-pocket costs for PrEP threaten key strategy in ending the HIV epidemic

Increasing patients' out of pocket costs for HIV pre-exposure prophylaxis (PrEP), medications, which have been shown to dramatically reduce the risk of HIV infection, could lead to a significant reduction in PrEP use and a rise in HIV infection rates, according to a new study co-led by researchers at the Perelman School of Medicine at the University of Pennsylvania and Johns Hopkins Bloomberg School of Public Health.

8 Jan 2024

40-year timeline of HIV: Testing assays, global burden, prevalence, treatment, and challenges

Announcing a new article publication for Zoonoses journal. More than 77 million individuals have been infected with the human immunodeficiency virus (HIV) and approximately 37.6 million people are living with HIV infection.

4 Jan 2024

Addiction stigma discourages many people from seeking treatment

Addiction is one of society's most misunderstood and rebuked health conditions. That stigma discourages many people from seeking treatment for substance dependence, according to a new report published in Psychological Science in the Public Interest, a journal of the Association for Psychological Science.

15 Dec 2023

NIAID study identifies critical T-cell function missing in prior HIV vaccine candidates

An effective HIV vaccine may need to prompt strong responses from immune cells called CD8+ T cells to protect people from acquiring HIV, according to a new study from researchers at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and colleagues.

14 Dec 2023

How does the combined effect of smoking and HIV infection influence the aging-related manifestations?

The combination of human immunodeficiency virus (HIV) infection and smoking influence.

12 Dec 2023

Closing the gender gap in HIV treatment could slash infection rates in Uganda

A study looking at 15 years of HIV transmission and suppression in Uganda reveals how closing gender gaps in treatment could slash infection rates.

8 Dec 2023

New early phase study evaluates “on-demand” HIV prevention method for women

A fast-dissolving vaginal insert that women would use at or around the time of sex as an "on-demand" HIV prevention method is being evaluated in a new early phase study being conducted by MATRIX, a United States Agency for International Development (USAID)-funded project focused on the early research and development of innovative HIV prevention products for women.

7 Dec 2023

Early treatment offers chance at medication-free remission for pediatric HIV patients

An unexpectedly high percentage of children, who were born with HIV and started treatment within 48 hours of life, exhibit biomarkers by 2 years of age that may make them eligible to test for medication-free remission, according to a multinational study published in Lancet HIV.

7 Dec 2023

Antiretroviral News and Research

Unlocking the anti-inflammatory secrets of bergamot byproducts

Study finds that HIV populations in people with higher viral loads also have higher rates of viral recombination

Paxlovid treatment in 20% of COVID-19 patients could avert 850,000 hospitalizations, save up to $170 billion

New study offers hope for reducing malaria in pregnant women living with HIV

Rising out-of-pocket costs for PrEP threaten key strategy in ending the HIV epidemic

40-year timeline of HIV: Testing assays, global burden, prevalence, treatment, and challenges

Addiction stigma discourages many people from seeking treatment

NIAID study identifies critical T-cell function missing in prior HIV vaccine candidates

How does the combined effect of smoking and HIV infection influence the aging-related manifestations?

Closing the gender gap in HIV treatment could slash infection rates in Uganda

New early phase study evaluates “on-demand” HIV prevention method for women

Early treatment offers chance at medication-free remission for pediatric HIV patients

Major UK study finds high demand and efficacy for HIV PrEP among sexual health service attendees

Study highlights importance of HIV prevention for migrants in EU/EEA

Canadian researchers aim to reduce chronic inflammation and comorbidities in HIV patients

Breakthrough in HIV treatment: NMN shows promise in reducing CD4+ T cell activation

Curcumin boosts brain delivery of HIV drug, curbing inflammation and oxidative stress

Immune response that protects against infections also drives HIV latency

Study reveals mechanisms underlying non-suppressible HIV viremia

US to cover HIV prevention drugs for older Americans to stem spread of the virus

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News